Some approaches to the therapeutic exploitation of metabolic sites of vulnerability of neoplastic cells.
D000963:Antimetabolites / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001665:Binding Sites; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy*
D000963:Antimetabolites; D000970:Antineoplastic Agents